New York State Dormitory Authority/Upstate Community Colleges Bonds Rated 'BBB+' Mar 99

  • ID: 1951881
  • March 1999
  • Region: New York
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's CreditWire) March 19, 1999--Standard & Poor's today assigned its triple-'B'-plus rating to New York State Dormitory Authority's $153.33 million revenue bonds series 1999, issued for New York's Upstate Community Colleges. The bonds are scheduled to sell March 24, 1999. Standard & Poor's also affirmed its triple-'B'-plus rating on the authority's outstanding series 1994A, 1995A, and 1997 revenue bonds, issued for the colleges. The rating reflects: -- The state's historical commitment to funding community college projects and operations; -- New York State's financial position single-'A' rated, and stable outlook); and -- Debt service payments subject to annual appropriation. Proceeds of bonds are sold to finance the state's (50%) share of $114 million of project costs on...

Companies mentioned in this report are:
- Dorm Auth of the St of New York

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Dorm Auth of the St of New York

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.